MAGNAPIME TZ 1.125gm Injection 1's

Mkt: Innovative Pharmaceuticals Pvt Ltd Country of Origin: India
MRP ₹350.00
Inclusive of all taxes
Get this at ₹287.00
Cart Total
₹0
MAGNAPIME TZ 1.125gm Injection 1's ₹287.00
MRP ₹350.00
Medicine requires valid prescription GOT IT
Request and get upto 20% OFF on high priced medicines. Request Now
Happy Customers 9M+ Happy Customers
Authentic Products 100% Authentic
Best Quality Quality Checked Products

Introduction About MAGNAPIME TZ 1.125GM INJECTION

MAGNAPIME TZ 1.125GM INJECTION is a fixed-dose combination of cefepime and tazobactam which belongs to the group of medicines called antibiotics. It is used to manage several bacterial infections like lower respiratory tract infections such as pneumonia, acute bacterial exacerbation causing breathing difficulties, urinary tract infections, pyelonephritis, skin infections, abdominal and biliary tract infections, vaginal infections, bacteraemia, and bacterial meningitis in infants and children.

MAGNAPIME TZ 1.125GM INJECTION is also used along with other antibacterial agents in the management of neutropenia caused by bacterial infection. Pneumonia is an infection that causes inflammation in the air sac, producing a cough with phlegm and shortness of breath. Pyelonephritis is a urinary tract infection affecting the urinary bladder that later spreads to the kidneys.

Bacteremia is an infectious condition indicating the presence of bacteria in the bloodstream. Bacterial meningitis is an infection caused by bacteria in the region surrounding the brain. Neutropenic means low levels of neutrophils (a type of white blood cell) in our body.

MAGNAPIME TZ 1.125GM INJECTION should not be used in patients allergic to penicillin antibiotics, cefepime, tazobactam and other beta-lactam antibiotics. MAGNAPIME TZ 1.125GM INJECTION should be used with caution in patients with kidney and liver diseases. Avoid using other aminoglycoside antibiotics and diuretics, and MAGNAPIME TZ 1.125GM INJECTION.

There is no proper information regarding the use of MAGNAPIME TZ 1.125GM INJECTION in pregnant women and so it should be used with caution in pregnant women. MAGNAPIME TZ 1.125GM INJECTION should be used with caution in breastfeeding women. MAGNAPIME TZ 1.125GM INJECTION should be used with caution in children above 2 months and elderly people. The common side effect of MAGNAPIME TZ 1.125GM INJECTION is injection site reactions such as pain and inflammation. Consult your doctor if any of your symptoms get worse or persist.

Uses Of MAGNAPIME TZ 1.125GM INJECTION

It is used to manage:

  • lower respiratory tract infections, such as pneumonia, and acute bacterial exacerbation causing breathing difficulties
  • uncomplicated and complicated urinary tract infections and pyelonephritis
  • skin and subcutaneous infections
  • intra-abdominal infections, including peritonitis and biliary tract infections
  • gynaecological infections
  • bacteraemia associated with other infections
  • bacterial meningitis in infants and children

Warning & Precautions

Synopsis

Drug :   cefepime, tazobactam
Pharmacological Category :   antibiotics
Therapeutic Indication :   bacterial infections
Dosage Forms :   injection

FAQs About MAGNAPIME TZ 1.125GM INJECTION

Q: Does MAGNAPIME TZ 1.125GM INJECTION cause any side effects?

A: Stop taking MAGNAPIME TZ 1.125GM INJECTION and contact your doctor immediately if you experience any of the following side effects: Swelling of the face, tongue, and throat, which can make breathing difficult, neurological effects such as encephalopathy (symptoms include unconsciousness, confusion, hallucinations, and coma), aphasia (inability to speak), seizures, and Clostridium difficile-associated diarrhoea.

Q: Will MAGNAPIME TZ 1.125GM INJECTION manage a COVID infection?

A: No, MAGNAPIME TZ 1.125GM INJECTION is not intended to manage COVID-19. MAGNAPIME TZ 1.125GM INJECTION is used widely in the management of bacteria, while the COVID-19 infection is a viral infection.

Q: Will MAGNAPIME TZ 1.125GM INJECTION manage different bacterial infections?

A: Yes, MAGNAPIME TZ 1.125GM INJECTION is indicated to manage several bacterial infections, such as lower respiratory tract infections, such as pneumonia, acute bacterial exacerbations causing breathing difficulties, uncomplicated and complicated urinary tract infections, and pyelonephritis. skin and subcutaneous infections, intra-abdominal infections, including peritonitis and biliary tract infections, gynaecological infections, bacteraemia associated with other infections, and bacterial meningitis in infants and children, and it is used along with other antibacterial agents in the management of neutropenia caused by bacterial infection.

Q: Can MAGNAPIME TZ 1.125GM INJECTION be used by children?

A: Yes, it is safe to use MAGNAPIME TZ 1.125GM INJECTION in children above 2 months of age; dose adjustments are necessary when used in children. Your doctor will decide the correct dose for your child depending on your child’s age and weight.

Q: How should I store MAGNAPIME TZ 1.125GM INJECTION?

A: Keep MAGNAPIME TZ 1.125GM INJECTION out of reach of children. Store at room temperature, no higher than 30 °C. Do not freeze MAGNAPIME TZ 1.125GM INJECTION.

Q: How will MAGNAPIME TZ 1.125GM INJECTION manage my infection?

A: MAGNAPIME TZ 1.125GM INJECTION works by destroying the bacterial growth responsible for causing infections. MAGNAPIME TZ 1.125GM INJECTION has two antibiotics: cefepime, a cephalosporin antibiotic, and tazobactam, a beta-lactam antibiotic. Cefepime works by interrupting cell wall formation by binding with the enzymes responsible for cell wall synthesis. This binding causes defects in the cell wall, leading to cell death and the death of the organism. Tazobactam, present in MAGNAPIME TZ 1.125GM INJECTION, is responsible for the irreversible termination of enzymes (beta-lactamases) that protect the organism from antibiotics. Tazobactam produces fewer anti-bacterial actions when given alone, so it’s always used in combination with other antibiotics. Thus, both substances work by managing cell growth and function by inhibiting bacterial growth.

Q: How long will MAGNAPIME TZ 1.125GM INJECTION take to manage bacterial infections?

A: MAGNAPIME TZ 1.125GM INJECTION will start working once it is injected into the bloodstream. It will work faster compared with oral antibiotics as it is injected directly into the bloodstream. However, the full course of antibiotics should be given to obtaining its efficacy. Your doctor will decide the dose adjustments and termination of the medicine depending on your health condition.

    Net Qty
    1 N
    Shelf Life
    720 Days
    Item Weight
    45 g
    Ingredient
    Cefepime 1000 mg+Tazobactam 125 mg
    Hsn Code
    30042019
Disclaimer:

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.